Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof

Details for Australian Patent Application No. 2010202722 (hide)

Owner Xenon Pharmaceuticals, Inc.

Inventors Ludwig, Erwin H.; Papanikolaou, George; MacDonald, Marcia L.E.; Samuels, Mark E.; Franchini, Patrick; Kamboj, Rajender K.; Goldberg, Yigal Paul

Agent Spruson & Ferguson

Pub. Number AU-A-2010202722

Parent 2004231122

Filing date 29 June 2010

Wipo publication date 15 July 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

15 July 2010 Application Open to Public Inspection

  Published as AU-A-2010202722

15 July 2010 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202723-Improved water heater

2010202721-Method for coating a medical device